Active Ingredient History
Gadoxetic acid is a gadolinium-based MRI contrast agent. Its salt, gadoxetate disodium, is marketed as Primovist in Europe and Eovist in the United States by Bayer HealthCare Pharmaceuticals. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Diagnostic Imaging (approved 2008)
Arteries (Phase 4)
Carcinoma, Hepatocellular (Phase 4)
Cognition (Phase 4)
Colorectal Neoplasms (Phase 4)
Contrast Media (Phase 4)
Fibrosis (Phase 4)
Liver (Phase 1/Phase 2)
Liver Diseases (Phase 3)
Liver Neoplasms (Phase 1)
Magnetic Resonance Imaging (Phase 3)
Motor Activity (Phase 4)
Neoplasm Metastasis (Phase 4)
Pharmacokinetics (Phase 1/Phase 2)
Prostatic Neoplasms (Phase 2)
Prostatic Neoplasms, Castration-Resistant (Early Phase 1)
Sports Medicine (Phase 1/Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue